Kathryn F Mileham

12PUBLICATIONS
78CO-AUTHORS
Molecular targetsRadiation therapyCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 30, 2026
Pertuzumab and Trastuzumab in Patients With ERBB2/3-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry Study.

|Apr 30, 2026
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With High Tumor Mutation Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.

|Oct 16, 2025
Olaparib in Patients With Solid Tumors With BRCA1/2 Alterations: Results From The Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Tareq Al Baghdadi, Michael Rothe, Pam K Mangat

|Nov 12, 2024
Interpretation of Reports and Translation to Community Oncologists: An Overview of Approaches.

Carol J Farhangfar, Kathryn F Mileham, Antoinette R Tan

|Sep 09, 2024
Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung Cancer.

Margaret R Smith, Caroline B Dixon, Yuezhu Wang

|Aug 22, 2023
Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non-Small-Cell Lung Cancer?

Kathryn F Mileham, Carol J Farhangfar

Pageof 2

Frequent Collaborators

5 joint publications

Elizabeth Garrett-Mayer

5 joint publications

Richard L Schilsky

4 joint publications

Dominique C Hinshaw

4 joint publications

Pam K Mangat